These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 20001955

  • 1. Complexities of oestrogen in stroke.
    Carswell HV, Macrae IM, Farr TD.
    Clin Sci (Lond); 2009 Dec 15; 118(6):375-89. PubMed ID: 20001955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oestrogen and stroke: the potential for harm as well as benefit.
    Macrae IM, Carswell HV.
    Biochem Soc Trans; 2006 Dec 15; 34(Pt 6):1362-5. PubMed ID: 17073819
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Dec 15; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 12. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 13. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM.
    Thromb Haemost; 2000 Dec 01; 84(6):961-7. PubMed ID: 11154141
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular risk and hormone replacement therapy.
    Lawlor DA, Smith GD.
    Curr Opin Obstet Gynecol; 2006 Dec 01; 18(6):658-65. PubMed ID: 17099339
    [Abstract] [Full Text] [Related]

  • 15. Estrogen replacement does not prevent recurrent stroke or death in postmenopausal women after an ischemic stroke.
    Basile JN.
    J Clin Hypertens (Greenwich); 2002 Dec 01; 4(1):48-9. PubMed ID: 11821638
    [No Abstract] [Full Text] [Related]

  • 16. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD.
    Ann N Y Acad Sci; 2005 Jun 01; 1052():57-74. PubMed ID: 16024751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HRT and cardiovascular disease.
    Stevenson JC.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 01; 23(1):109-20. PubMed ID: 19095500
    [Abstract] [Full Text] [Related]

  • 19. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
    Burckhardt P.
    Schweiz Med Wochenschr; 1999 Dec 11; 129(49):1926-30. PubMed ID: 10635085
    [Abstract] [Full Text] [Related]

  • 20. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T, Mannella P, Genazzani AR.
    Recenti Prog Med; 2003 Feb 11; 94(2):51-6. PubMed ID: 12908369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.